| Zachary Belford, DO | |
|
2902 Mcfarland Rd, Rockford, IL 61107-6801 | |
| (815) 316-7300 | |
| Not Available |
| Full Name | Zachary Belford |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Pain Medicine |
| Location | 2902 Mcfarland Rd, Rockford, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659894913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 036.160739 (Illinois) | Primary |
| Entity Name | Rockford Pain Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689991713 PECOS PAC ID: 1658403357 Enrollment ID: O20100715000607 |
News Archive
TomoTherapy Incorporated announced today that the Institute Curie Hospital in France has purchased a second TomoTherapy® radiation therapy system, to support the increasing demand for intensity-modulated radiation therapy (IMRT). The Institute Curie Hospital has been treating cancer patients with TomoTherapy technology since March 2007, when it became the first hospital in France to adopt the technology.
More support needs to be put in place for hospital workers dealing with the Covid pandemic after a global review of studies found high levels of depression, PTSD, anxiety and burn-out amongst frontline staff.
AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo
Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated by substantial decreases in the levels of alkaline phosphatase (AP) enzyme in the blood, a key marker for PBC.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zachary Belford, DO 2902 Mcfarland Rd, Rockford, IL 61107-6801 Ph: (815) 316-7300 | Zachary Belford, DO 2902 Mcfarland Rd, Rockford, IL 61107-6801 Ph: (815) 316-7300 |
News Archive
TomoTherapy Incorporated announced today that the Institute Curie Hospital in France has purchased a second TomoTherapy® radiation therapy system, to support the increasing demand for intensity-modulated radiation therapy (IMRT). The Institute Curie Hospital has been treating cancer patients with TomoTherapy technology since March 2007, when it became the first hospital in France to adopt the technology.
More support needs to be put in place for hospital workers dealing with the Covid pandemic after a global review of studies found high levels of depression, PTSD, anxiety and burn-out amongst frontline staff.
AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo
Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated by substantial decreases in the levels of alkaline phosphatase (AP) enzyme in the blood, a key marker for PBC.
› Verified 6 days ago
Pirojna Jantra, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2825 Glenwood Ave, Rockford, IL 61101 Phone: 815-965-9712 | |
Ryan C Enke, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 | |
Sean P Mackenzie, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 324 Roxbury Rd, Rockford, IL 61107 Phone: 815-398-9491 Fax: 815-381-7498 | |
Dr. Kumud Nigam, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6957 Olde Creek Rd, Suite #3400, Rockford, IL 61114 Phone: 815-397-6276 Fax: 815-397-2266 | |
Dr. Zeeshan Ahmad, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 | |
Mrs. Christine M Pedersen, MSPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6905 E State St, Rockford, IL 61108 Phone: 815-397-4142 Fax: 815-397-4144 | |
Carly Renee Ditto, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1401 E State St, Rockford, IL 61104 Phone: 815-540-6299 |